| Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone. | |
| | |
MedLine Citation:
|
PMID: 18631328 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: We aimed to investigate associations between serum levels of the advanced glycation endproduct methylglyoxal-derived hydroimidazolone (MG-H1) and retinopathy in a sample of patients with type 1 diabetes. METHODS: We conducted a cross-sectional study in a Scandinavian ophthalmology outpatient clinic on 61 randomly selected patients with type 1 diabetes. Blood samples and retinal photographs were taken at the same visit. Serum levels of hydroimidazolone immunoreactivity were determined using an immunoassay, and levels of retinopathy were determined from seven standard field stereo photographs of each eye according to the ETDRS method. Results were compared between patients with and without retinopathy. RESULTS: Hydroimidazolone quartiles were significantly associated with retinopathy (p = 0.013). The most profound increase in occurrence of retinopathy was observed from the lowest to the second-lowest hydroimidazolone quartile. Adjusted for duration of diabetes using logistic regression, a significant difference in the presence of retinopathy was found when comparing the lowest quartile with the rest (p = 0.022). CONCLUSIONS: In our patients with type 1 diabetes, serum levels of hydroimidazolone were found to be associated with retinopathy. This is in keeping with findings in a larger sample of patients with type 2 diabetes. |
| | |
Authors:
|
Dag S Fosmark; Jens P Berg; Aase-Brith Jensen; Leiv Sandvik; Elisabet Agardh; Carl-David Agardh; Kristian F Hanssen |
Related Documents
:
|
9375578 - Mapping of retinal function in diabetic retinopathy using the multifocal electroretinog... 20212888 - Lasers in ophthalmology: the path from theory to application. 15675198 - The effect of post prandial glucose changes on oscillatory potentials in subjects with ... 756468 - Immune complexes and diabetic microangiopathy. 7817388 - Three types of "mid-band" lipoproteins in non-insulin-dependent diabetes mellitus: rela... 20001678 - Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control i... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't Date: 2008-07-09 |
Journal Detail:
|
Title: Acta ophthalmologica Volume: 87 ISSN: 1755-3768 ISO Abbreviation: - Publication Date: 2009 Aug |
Date Detail:
|
Created Date: 2009-08-11 Completed Date: 2009-11-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101468102 Medline TA: Acta Ophthalmol Country: England |
Other Details:
|
Languages: eng Pagination: 498-500 Citation Subset: IM |
Affiliation:
|
Diabetes Research Centre, Aker and Ullevål University Hospitals, Oslo, Norway. dag.fosmark@medisin.uio.no |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Cross-Sectional Studies Diabetes Mellitus, Type 1 / blood* Diabetic Retinopathy / blood*, epidemiology*, pathology Female Fundus Oculi Glycosylation End Products, Advanced / blood* Hemoglobin A, Glycosylated / metabolism Humans Imidazoles / blood* Immunoassay Male Middle Aged Prevalence Pyruvaldehyde / metabolism Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Glycosylation End Products, Advanced; 0/Hemoglobin A, Glycosylated; 0/Imidazoles; 0/hemoglobin A1c protein, human; 0/imidazolone; 78-98-8/Pyruvaldehyde |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Macular microcirculation in hypertensive patients with and without branch retinal vein occlusion.
Next Document: Comparison of two partial coherence interferometers for corneal pachymetry in high myopia and after ...